Cargando…
Thiamine transporter-2 deficiency: outcome and treatment monitoring
BACKGROUND: The clinical characteristics distinguishing treatable thiamine transporter-2 deficiency (ThTR2) due to SLC19A3 genetic defects from the other devastating causes of Leigh syndrome are sparse. METHODS: We report the clinical follow-up after thiamine and biotin supplementation in four child...
Autores principales: | Ortigoza-Escobar, Juan Darío, Serrano, Mercedes, Molero, Marta, Oyarzabal, Alfonso, Rebollo, Mónica, Muchart, Jordi, Artuch, Rafael, Rodríguez-Pombo, Pilar, Pérez-Dueñas, Belén |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099387/ https://www.ncbi.nlm.nih.gov/pubmed/24957181 http://dx.doi.org/10.1186/1750-1172-9-92 |
Ejemplares similares
-
Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy
por: Izquierdo-Serra, Mercè, et al.
Publicado: (2018) -
Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment
por: Serrano, Mercedes, et al.
Publicado: (2015) -
Hypermanganesemia due to mutations in SLC39A14: further insights into Mn deposition in the central nervous system
por: Marti-Sanchez, L., et al.
Publicado: (2018) -
Thiamine deficiency affects glucose transport and β‐oxidation in rats
por: Gralak, Mikołaj Antoni, et al.
Publicado: (2019) -
Thiamine Deficiency in a Patient With Schizophrenia: Precautions and Countermeasures for Subclinical Thiamine Deficiency
por: Ishida, Mayumi, et al.
Publicado: (2023)